MarketCatalystCACI International beat first-quarter adjusted EPS estimates by $1.09 but missed on revenue. It raised its fiscal 2027 revenue and EPS guidance and held its free cash flow outlook at $900 million or more.
IBM topped Q3 estimates on operating EPS of $2.95 and revenue of $17.1 billion, up 5% as software accelerated and infrastructure rebounded. It held its 4% to 5% revenue growth outlook and raised its free cash flow outlook.
Tesla beat Q3 EPS estimates by $0.03 on revenue in line with consensus. Margins rebounded and free cash flow topped forecasts, but profit fell, energy storage missed and management gave no numeric outlook.
Broad market advances on strong tech earnings and a steady Fed outlook, while energy and health stocks lag.
Meta reported $7.40 of EPS excluding a $9.89 billion legal charge, topping the $6.54 consensus, on revenue up 26% to $64.6 billion. It guided Q4 revenue above estimates, raised its 2026 expense outlook and approved a new class of non-voting stock.
Abbott will separate its Nutrition business into a standalone public company by the end of 2027. Q3 earnings were in line, but a weaker electrophysiology and diabetes outlook cut 2026 sales growth to about 6%.